Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehran Karimi

Showing results (301-310 of 315) with videos related to

Pageof 32
Sort By:
British Journal of Haematology|October 26, 2021
Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemiaKhaled M Musallam, Angela Vitrano, Antonella Meloni, et al.
Endocrine|December 20, 2019
Evaluation of endocrine complications in beta-thalassemia intermedia (β-TI): a cross-sectional multicenter studyMehran Karimi, Tahereh Zarei, Sezaneh Haghpanah, et al.
American Journal of Hematology|December 4, 2021
Risk of mortality from anemia and iron overload in nontransfusion-dependent β-thalassemiaKhaled M Musallam, Angela Vitrano, Antonella Meloni, et al.
Haematologica|April 22, 2021
Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemiaKhaled M Musallam, Angela Vitrano, Antonella Meloni, et al.
Acta Bio-Medica : Atenei Parmensis|September 14, 2020
A comprehensive update of ICET-A Network on COVID-19 in thalassemias: what we know and where we standVincenzo De Sanctis, Duran Canatan, Joan Lluis Vives Corrons, et al.
Blood Cells, Molecules & Diseases|December 4, 2022
Development of a Thalassemia International Prognostic Scoring System (TIPSS)Angela Vitrano, Khaled M Musallam, Antonella Meloni, et al.
Acta Bio-Medica : Atenei Parmensis|January 20, 2018
An ICET- A survey on Hypoparathyroidism in Patients with Thalassaemia Major and Intermedia: A preliminary reportVincenzo De Sanctis, Ashraf T Soliman, Duran Canatan, et al.
Journal of Thrombosis and Haemostasis : JTH|February 15, 2023
von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPSMaria Teresa Pagliari, Ulrich Budde, Luciano Baronciani, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 20, 2025
A Multicenter ICET-A Survey on Adherence to Annual Oral Glucose Tolerance Test (OGTT) Screening in Transfusion-Dependent Thalassemia (TDT) Patients - The Expert Clinicians' Opinion on Factors Influencing the Adherence and on Alternative Strategies for Adherence OptimizationVincenzo de Sanctis, Duran Canatan, Shahina Daar, et al.
Journal of Thrombosis and Haemostasis : JTH|January 29, 2022
Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS studyMaria Teresa Pagliari, Frits R Rosendaal, Minoo Ahmadinejad, et al.
Pageof 32

Showing results (301-310 of 315) with videos related to

Sort By:
Pageof 32
British Journal of Haematology|October 26, 2021
Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemiaKhaled M Musallam, Angela Vitrano, Antonella Meloni, et al.
Endocrine|December 20, 2019
Evaluation of endocrine complications in beta-thalassemia intermedia (β-TI): a cross-sectional multicenter studyMehran Karimi, Tahereh Zarei, Sezaneh Haghpanah, et al.
American Journal of Hematology|December 4, 2021
Risk of mortality from anemia and iron overload in nontransfusion-dependent β-thalassemiaKhaled M Musallam, Angela Vitrano, Antonella Meloni, et al.
Haematologica|April 22, 2021
Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemiaKhaled M Musallam, Angela Vitrano, Antonella Meloni, et al.
Acta Bio-Medica : Atenei Parmensis|September 14, 2020
A comprehensive update of ICET-A Network on COVID-19 in thalassemias: what we know and where we standVincenzo De Sanctis, Duran Canatan, Joan Lluis Vives Corrons, et al.
Blood Cells, Molecules & Diseases|December 4, 2022
Development of a Thalassemia International Prognostic Scoring System (TIPSS)Angela Vitrano, Khaled M Musallam, Antonella Meloni, et al.
Acta Bio-Medica : Atenei Parmensis|January 20, 2018
An ICET- A survey on Hypoparathyroidism in Patients with Thalassaemia Major and Intermedia: A preliminary reportVincenzo De Sanctis, Ashraf T Soliman, Duran Canatan, et al.
Journal of Thrombosis and Haemostasis : JTH|February 15, 2023
von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPSMaria Teresa Pagliari, Ulrich Budde, Luciano Baronciani, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 20, 2025
A Multicenter ICET-A Survey on Adherence to Annual Oral Glucose Tolerance Test (OGTT) Screening in Transfusion-Dependent Thalassemia (TDT) Patients - The Expert Clinicians' Opinion on Factors Influencing the Adherence and on Alternative Strategies for Adherence OptimizationVincenzo de Sanctis, Duran Canatan, Shahina Daar, et al.
Journal of Thrombosis and Haemostasis : JTH|January 29, 2022
Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS studyMaria Teresa Pagliari, Frits R Rosendaal, Minoo Ahmadinejad, et al.
Pageof 32